243 related articles for article (PubMed ID: 10873574)
21. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
[TBL] [Abstract][Full Text] [Related]
22. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
23. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
24. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
[TBL] [Abstract][Full Text] [Related]
25. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
26. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo.
Mao Y; Ling PR; Fitzgibbons TP; McCowen KC; Frick GP; Bistrian BR; Smith RJ
Endocrinology; 1999 Dec; 140(12):5505-15. PubMed ID: 10579313
[TBL] [Abstract][Full Text] [Related]
27. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
[TBL] [Abstract][Full Text] [Related]
28. Dexamethasone inhibits early regenerative response of rat liver after cold preservation and transplantation.
Debonera F; Krasinkas AM; Gelman AE; Aldeguer X; Que X; Shaked A; Olthoff KM
Hepatology; 2003 Dec; 38(6):1563-72. PubMed ID: 14647067
[TBL] [Abstract][Full Text] [Related]
29. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.
Park ES; Kim H; Suh JM; Park SJ; You SH; Chung HK; Lee KW; Kwon OY; Cho BY; Kim YK; Ro HK; Chung J; Shong M
Mol Endocrinol; 2000 May; 14(5):662-70. PubMed ID: 10809230
[TBL] [Abstract][Full Text] [Related]
30. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.
Yamada Y; Webber EM; Kirillova I; Peschon JJ; Fausto N
Hepatology; 1998 Oct; 28(4):959-70. PubMed ID: 9755232
[TBL] [Abstract][Full Text] [Related]
31. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract][Full Text] [Related]
32. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
Williams L; Bradley L; Smith A; Foxwell B
J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 augments hepatocyte growth factor-induced liver regeneration; involvement of STAT3 activation.
Kaido T; Oe H; Imamura M
Hepatogastroenterology; 2004; 51(60):1667-70. PubMed ID: 15532800
[TBL] [Abstract][Full Text] [Related]
34. Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II.
Duplomb L; Chaigne-Delalande B; Vusio P; Raher S; Jacques Y; Godard A; Blanchard F
Endocrinology; 2003 Dec; 144(12):5381-9. PubMed ID: 12959977
[TBL] [Abstract][Full Text] [Related]
35. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor.
Yamada Y; Fausto N
Am J Pathol; 1998 Jun; 152(6):1577-89. PubMed ID: 9626061
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor primes hepatocytes for DNA replication in the rat.
Webber EM; Bruix J; Pierce RH; Fausto N
Hepatology; 1998 Nov; 28(5):1226-34. PubMed ID: 9794905
[TBL] [Abstract][Full Text] [Related]
37. [Influence on the cytokines expression on hepatic tissue by inhibition the signal pathway of inflammatory mediators following extensive hepatectomy in rats].
Mao YL; Yu Z; Sang XT; Lu X; Yang ZY; Zhong SX
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):6-9. PubMed ID: 15774164
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
Cheng J; Zhang D; Zhou C; Marasco WA
Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
[TBL] [Abstract][Full Text] [Related]
39. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
Brand S; Dambacher J; Beigel F; Zitzmann K; Heeg MH; Weiss TS; Prüfer T; Olszak T; Steib CJ; Storr M; Göke B; Diepolder H; Bilzer M; Thasler WE; Auernhammer CJ
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1019-28. PubMed ID: 17204547
[TBL] [Abstract][Full Text] [Related]
40. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
